'The initial public offer (IPO) of Clinitech Laboratory received bids for 2,22,86,000 shares as against 6,02,400 shares on offer. The issue was subscribed 36.99 times.
Retail investors bid for 1,49,41,000 shares, non-institutional investors bid for 70,44,000 shares and qualified institutional investors bid for 3,01,000 shares.
The issue opened for bidding on 25 July 2024 and it closed on 29 July 2024. The price of the IPO was fixed at Rs 96 per share. The equity shares will list on BSE’s SME platform.
The IPO comprised fresh issue of 6,02,400 equity shares. The promoter and promoter group shareholding diluted to 61.57% from 83.65% pre-issue.
The company intends to utilize the net proceeds for expansion of diagnostic centres and general corporate purpose.
Clinitech Laboratory is a diagnostic services company with 8 centers in Thane and Navi Mumbai. They offer over 150 types of medical tests, including blood work, immunology, and pathology. The company empl...
Pleaselogin & subscribe to view the full report.
More Reports
-
(05-Feb-2025)
Castrol India
Expects EBITDA margin of 22%-25% for CY25
-
(10-Feb-2023)
Deepak Nitrite
Plans capex of about Rs 1500 crore for FY23 and FY24
-
(09-Feb-2023)
Mayur Uniquoters
Targets revenue of Rs 1000 crore in FY24
-
(31-Jan-2023)
Tega industries
Capex plan is US$ 30-32 million for next three years
|
|